RLAY stock soars on positive interim efficacy data from the early-stage study of its doublet therapy, RLY-2608 in combination with Faslodex, for...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - Times of India - Science - 01/Sep 06:29
Unapproved formulations accounted for over 60 pc of psychotropic FDCs from 2008-2020: Study
A study found unapproved formulations accounted for over 60% of psychotropic fixed dose combination drug sales in India from 2008 to 2020. The report highlights risks due to a lack of safety and efficacy evaluation, urging enhanced regulatory measures and market surveillance to mitigate potential public health threats.
Articles similaires
Relay Stock Soars on Upbeat Data From Breast Cancer Study
zacks.com - 10/Sep 14:55
RLAY stock soars on positive interim efficacy data from the early-stage study of its doublet therapy, RLY-2608 in combination with Faslodex, for...
Evolution Of Live Reporting And Interviewing Techniques In Contemporary Audiovisual Journalism: Assessing Challenges In Breaking News Situations – Analysis
eurasiareview.com - 09/Sep 23:00
A Changing Landscape The emergence of mobile technology, social media, and high-speed internet has democratized live reporting, allowing...
IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab
zacks.com - 09/Sep 12:35
Immunovant stock rises on mid-stage study data of batoclimab for Graves' Disease, showing superior efficacy compared to anti-thyroid drug therapy...
IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab
zacks.com - 09/Sep 12:35
Immunovant stock rises on mid-stage study data of batoclimab for Graves' Disease, showing superior efficacy compared to anti-thyroid drug therapy...
In a First-of-its-kind Fixed Dose Study, Once Weekly Insulin Efsitora Alfa Leads to A1C Reduction Similar to Daily Insulin
drugs.com - 05/Sep 06:09
INDIANAPOLIS, Sept. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the QWINT-1 and QWINT-3...
In a First-of-its-kind Fixed Dose Study, Once Weekly Insulin Efsitora Alfa Leads to A1C Reduction Similar to Daily Insulin
drugs.com - 05/Sep 06:09
INDIANAPOLIS, Sept. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the QWINT-1 and QWINT-3...
GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal
zacks.com - 12/Sep 15:36
The phase I/II proof-of-concept study evaluating GSK's herpes simplex virus vaccine candidate, GSK3943104, fails to meet the primary efficacy...
GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal
zacks.com - 12/Sep 15:36
The phase I/II proof-of-concept study evaluating GSK's herpes simplex virus vaccine candidate, GSK3943104, fails to meet the primary efficacy...
Understanding Islamic Finance – Analysis
eurasiareview.com - 02/Sep 22:39
A bit of history Islamic finance during the time of the Prophet Muhammad was characterized by real transactions such as sale on credit and...
Les derniers communiqués
-
Aucun élément